|
CAPN7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62936331093988E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3988810110277E-14 |
| Normal-vs-Stage2 |
1.09960041072554E-10 |
| Normal-vs-Stage3 |
1.62503344114384E-12 |
| Normal-vs-Stage4 |
1.6251444634463E-12 |
| Stage1-vs-Stage2 |
4.300600E-01 |
| Stage1-vs-Stage3 |
1.397790E-01 |
| Stage1-vs-Stage4 |
7.762500E-02 |
| Stage2-vs-Stage3 |
8.884100E-02 |
| Stage2-vs-Stage4 |
4.260100E-02 |
| Stage3-vs-Stage4 |
5.530600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62680979798324E-12 |
| Normal-vs-AfricanAmerican |
4.03000000004372E-06 |
| Normal-vs-Asian |
1.64268598723538E-12 |
| Caucasian-vs-AfricanAmerican |
6.288400E-02 |
| Caucasian-vs-Asian |
8.458200E-01 |
| AfricanAmerican-vs-Asian |
1.159210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99200722162641E-16 |
| Normal-vs-Female |
1.63424829224823E-12 |
| Male-vs-Female |
2.755400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63258295771129E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
6.10622663543836E-15 |
| Normal-vs-Age(81-100Yrs) |
3.98780000000487E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.768200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.131400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.743000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.154600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.166200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.752400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.765700E-04 |
| Classical-VS-Follicular |
2.129400E-01 |
| Classical-VS-Other |
4.277200E-01 |
| Classical-VS-Normal |
9.63673585374636E-14 |
| Tall-VS-Follicular |
2.586400E-04 |
| Tall-VS-Other |
4.679400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.998800E-01 |
| Follicular-VS-Normal |
6.27065066538535E-12 |
| Other-VS-Normal |
8.4760000000017E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
7.66053886991358E-15 |
| N0-vs-N1 |
7.675600E-02 |
|
|
